# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-20-138276
Filing Date
2020-05-11
Accepted
2020-05-11 07:36:52
Documents
59
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d929610d8k.htm iXBRL | 8-K | 29135
2 | EX-99.1 | d929610dex991.htm | EX-99.1 | 82329
3 | EX-99.2 | d929610dex992.htm | EX-99.2 | 49402
7 | GRAPHIC | g929610ex99_2s10g1.jpg | GRAPHIC | 216977
8 | GRAPHIC | g929610ex99_2s11g1.jpg | GRAPHIC | 267597
9 | GRAPHIC | g929610ex99_2s12g1.jpg | GRAPHIC | 154284
10 | GRAPHIC | g929610ex99_2s13g1.jpg | GRAPHIC | 230266
11 | GRAPHIC | g929610ex99_2s14g1.jpg | GRAPHIC | 210328
12 | GRAPHIC | g929610ex99_2s15g1.jpg | GRAPHIC | 217740
13 | GRAPHIC | g929610ex99_2s16g1.jpg | GRAPHIC | 154725
14 | GRAPHIC | g929610ex99_2s17g1.jpg | GRAPHIC | 286427
15 | GRAPHIC | g929610ex99_2s18g1.jpg | GRAPHIC | 135530
16 | GRAPHIC | g929610ex99_2s19g1.jpg | GRAPHIC | 238748
17 | GRAPHIC | g929610ex99_2s1g1.jpg | GRAPHIC | 316258
18 | GRAPHIC | g929610ex99_2s20g1.jpg | GRAPHIC | 220756
19 | GRAPHIC | g929610ex99_2s21g1.jpg | GRAPHIC | 223678
20 | GRAPHIC | g929610ex99_2s22g1.jpg | GRAPHIC | 332138
21 | GRAPHIC | g929610ex99_2s23g1.jpg | GRAPHIC | 101061
22 | GRAPHIC | g929610ex99_2s24g1.jpg | GRAPHIC | 250362
23 | GRAPHIC | g929610ex99_2s25g1.jpg | GRAPHIC | 334754
24 | GRAPHIC | g929610ex99_2s26g1.jpg | GRAPHIC | 208004
25 | GRAPHIC | g929610ex99_2s27g1.jpg | GRAPHIC | 159841
26 | GRAPHIC | g929610ex99_2s28g1.jpg | GRAPHIC | 189424
27 | GRAPHIC | g929610ex99_2s29g1.jpg | GRAPHIC | 111049
28 | GRAPHIC | g929610ex99_2s2g1.jpg | GRAPHIC | 407337
29 | GRAPHIC | g929610ex99_2s30g1.jpg | GRAPHIC | 267609
30 | GRAPHIC | g929610ex99_2s31g1.jpg | GRAPHIC | 252604
31 | GRAPHIC | g929610ex99_2s32g1.jpg | GRAPHIC | 297557
32 | GRAPHIC | g929610ex99_2s33g1.jpg | GRAPHIC | 183509
33 | GRAPHIC | g929610ex99_2s34g1.jpg | GRAPHIC | 227349
34 | GRAPHIC | g929610ex99_2s35g1.jpg | GRAPHIC | 227048
35 | GRAPHIC | g929610ex99_2s36g1.jpg | GRAPHIC | 206771
36 | GRAPHIC | g929610ex99_2s37g1.jpg | GRAPHIC | 102245
37 | GRAPHIC | g929610ex99_2s38g1.jpg | GRAPHIC | 279639
38 | GRAPHIC | g929610ex99_2s39g1.jpg | GRAPHIC | 256855
39 | GRAPHIC | g929610ex99_2s3g1.jpg | GRAPHIC | 182073
40 | GRAPHIC | g929610ex99_2s40g1.jpg | GRAPHIC | 294145
41 | GRAPHIC | g929610ex99_2s41g1.jpg | GRAPHIC | 266640
42 | GRAPHIC | g929610ex99_2s42g1.jpg | GRAPHIC | 274010
43 | GRAPHIC | g929610ex99_2s43g1.jpg | GRAPHIC | 186076
44 | GRAPHIC | g929610ex99_2s44g1.jpg | GRAPHIC | 288430
45 | GRAPHIC | g929610ex99_2s4g1.jpg | GRAPHIC | 216746
46 | GRAPHIC | g929610ex99_2s5g1.jpg | GRAPHIC | 112308
47 | GRAPHIC | g929610ex99_2s6g1.jpg | GRAPHIC | 284864
48 | GRAPHIC | g929610ex99_2s7g1.jpg | GRAPHIC | 311634
49 | GRAPHIC | g929610ex99_2s8g1.jpg | GRAPHIC | 257736
50 | GRAPHIC | g929610ex99_2s9g1.jpg | GRAPHIC | 389195
51 | GRAPHIC | g929610g0511030708754.jpg | GRAPHIC | 6239
| Complete submission text file | 0001193125-20-138276.txt |  | 14557422

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | wve-20200511.xsd | EX-101.SCH | 3090
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | wve-20200511_lab.xml | EX-101.LAB | 17305
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | wve-20200511_pre.xml | EX-101.PRE | 10943
55 | EXTRACTED XBRL INSTANCE DOCUMENT | d929610d8k_htm.xml | XML | 3272

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 20862636
SIC: 2834 Pharmaceutical Preparations